Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
BNTC
Stock Latest News
Ratings
Reiterating Buy on Benitec: Promising Early BB-301 Data in OPMD Underpin $32 12‑Month Target
14d ago
BNTC
Premium
The Fly
Benitec Biopharma announces interim Phase 1b/2a study of BB-301
14d ago
BNTC
Premium
Ratings
Benitec Biopharma: Emerging BB-301 Clinical Profile and Upcoming Data Catalyst Support Buy Rating and $32 Target
21d ago
BNTC
Premium
The Fly
Benitec Biopharma reports Q2 EPS (26c) vs (26c) last year
1M ago
BNTC
Premium
The Fly
Benitec Biopharma files to sell 1.48M shares of common stock for holders
2M ago
BNTC
Premium
The Fly
Benitec Biopharma first patient treated in Cohort 1 of BB-301 Phase 1b/2a study
2M ago
BNTC
Premium
Company Announcements
Benitec Biopharma Concludes 2025 Annual Stockholders Meeting
4M ago
8K
BNTC
Premium
The Fly
Benitec Biopharma price target lowered to $32 from $35 at H.C. Wainwright
4M ago
BNTC
Premium
Ratings
Benitec Biopharma: Strong Financial Position and Promising Clinical Developments Justify Buy Rating
4M ago
BNTC
Premium
The Fly
Citizens JMP healthcare analysts hold an analyst/industry conference
4M ago
BNTC
CRSP
Premium
Company Announcements
Benitec Biopharma Reports Increased Quarterly Loss Amid Rising Expenses
4M ago
BNTC
Premium
The Fly
Benitec Biopharma reports Q1 EPS (22c), consensus (33c)
4M ago
BNTC
Premium
Company Announcements
Benitec Biopharma Announces $100 Million Public Offering
5M ago
8K
BNTC
Premium
The Fly
Benitec Biopharma $100M share Spot Secondary priced at $13.50
5M ago
BNTC
Premium
The Fly
Benitec Biopharma announces common stock offering, no amount given
5M ago
BNTC
Premium
Ratings
Positive Buy Rating for BB-301 Driven by Promising Trial Results and Potential Market Acceleration
5M ago
BNTC
Premium
The Fly
Benitec Biopharma price target raised to $35 from $28 at H.C. Wainwright
5M ago
BNTC
Premium
The Fly
Benitec Biopharma price target raised to $22 from $20 at Citizens JMP
5M ago
BNTC
Premium
Company Announcements
Benitec Biopharma’s BB-301 Receives FDA Fast Track
5M ago
8K
BNTC
Premium
The Fly
Benitec provide interim clinical results for BB-301 Phase 1b/2a trial of BB-301
5M ago
BNTC
Premium
The Fly
Benitec Biopharma appoints Mates to board of directors
5M ago
BNTC
Premium
Company Announcements
Benitec Biopharma’s BB-301 Study: A Potential Game-Changer for OPMD Treatment?
5M ago
BNTC
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
